Factors associated with neutrophil recovery: multivariate analysis
| Factors . | RR (95% CI) . | P value compared with reference group . | P value compared with second reference group . |
|---|---|---|---|
| Conditioning regimen | |||
| No FLU + TBI* | 1.0 | <.01 | |
| FLU + TBI 450 cGy† | 2.6 (1.3-5.1) | <.01 | |
| FLU + TBI 300 cGy | 2.9 (1.4-6.2) | <.01 | .60 |
| Hematopoietic stem cell source | |||
| HLA-matched TCD URD BM* | 1.0 | ||
| 1-Ag HLA-mismatched TCD URD BM | 0.7 (0.4-1.3) | .27 | |
| 1-Ag HLA-mismatched TCD RD BM | 0.6 (0.2-1.7) | .35 | |
| URD UCB | 0.2 (0.1-0.4) | <.01 | |
| Androgen use | |||
| No* | 1.0 | ||
| Yes | 0.7 (0.4-1.1) | .15 |
| Factors . | RR (95% CI) . | P value compared with reference group . | P value compared with second reference group . |
|---|---|---|---|
| Conditioning regimen | |||
| No FLU + TBI* | 1.0 | <.01 | |
| FLU + TBI 450 cGy† | 2.6 (1.3-5.1) | <.01 | |
| FLU + TBI 300 cGy | 2.9 (1.4-6.2) | <.01 | .60 |
| Hematopoietic stem cell source | |||
| HLA-matched TCD URD BM* | 1.0 | ||
| 1-Ag HLA-mismatched TCD URD BM | 0.7 (0.4-1.3) | .27 | |
| 1-Ag HLA-mismatched TCD RD BM | 0.6 (0.2-1.7) | .35 | |
| URD UCB | 0.2 (0.1-0.4) | <.01 | |
| Androgen use | |||
| No* | 1.0 | ||
| Yes | 0.7 (0.4-1.1) | .15 |